Pain Research
Pain Research(疼痛研究)
Pain Research 相关产品(223)
- GC41685(±)-WIN 55,212 (mesylate)CAS: 137795-17-6纯度: >98.00%
A racemic mixture of (+)-WIN 55,212-2 and (?)-WIN 55,212-3
- GC422583-Cysteinylacetaminophen (trifluoroacetate salt)CAS: 1331891-93-0纯度: >98.00%
An acetaminophen-protein adduct
- GC424024-hydroxy (S)-Duloxetine β-D-Glucuronide (sodium salt)纯度: >95.00%
An inactive metabolite of (S)-duloxetine
- GC425806-hydroxy ChlorzoxazoneCAS: 1750-45-4纯度: >97.00%
6-hydroxy Chlorzoxazone是Chlorzoxazone在体内的主要代谢产物。6-hydroxy Chlorzoxazone主要通过肝脏细胞色素P450酶系统形成，在生化研究中常作为探针用于定量评估CYP2E1的活性。
- GC42693Acetaminophen Glucuronide (sodium salt)CAS: 120595-80-4纯度: >98.00%
An inactive metabolite of acetaminophen
- GC42694Acetaminophen sulfate (potassium salt)CAS: 32113-41-0纯度: >98.00%
An inactive metabolite of acetaminophen
- GC42704Acetyl β-Endorphin (human) (trifluoroacetate salt)纯度: >95.00%
An acetylated derivative of β-endorphin
- GC42809Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt)纯度: >95.00%
A peptide vasoconstrictor
- GC42934Biocytin-β-Endorphin (human) (trifluoroacetate salt)纯度: >95.00%
A biocytin-conjugated form of β-endorphin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41191 | (±)13(14)-EpDPA | 895127-64-7 | >95.00% | |
A DHA epoxygenase metabolite | ||||
| GC41203 | (±)7(8)-EpDPA | 895127-66-9 | >95.00% | |
A DHA epoxygenase metabolite | ||||
| GC41270 | N-desmethyl Zolmitriptan | 139264-35-0 | >95.00% | |
An active metabolite of zolmitriptan | ||||
| GC41499 | α-Phellandrene | 99-83-2 | >80.00% | |
A monoterpene with diverse biological activities | ||||
| GC41599 | URB754 | 86672-58-4 | >98.00% | |
A MAGL inhibitor | ||||
| GC41685 | (±)-WIN 55,212 (mesylate) | 137795-17-6 | >98.00% | |
A racemic mixture of (+)-WIN 55,212-2 and (?)-WIN 55,212-3 | ||||
| GC41697 | (Ala1)-PAR4 (1-6) amide (mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide agonist of PAR4 | ||||
| GC42258 | 3-Cysteinylacetaminophen (trifluoroacetate salt) | 1331891-93-0 | >98.00% | |
An acetaminophen-protein adduct | ||||
| GC42402 | 4-hydroxy (S)-Duloxetine β-D-Glucuronide (sodium salt) | - | >95.00% | |
An inactive metabolite of (S)-duloxetine | ||||
| GC42550 | 5-hydroxy-6-methoxy (S)-Duloxetine | 741693-79-8 | >95.00% | |
A metabolite of (S)-duloxetine | ||||
| GC42580 | 6-hydroxy Chlorzoxazone | 1750-45-4 | >97.00% | |
6-hydroxy Chlorzoxazone是Chlorzoxazone在体内的主要代谢产物。6-hydroxy Chlorzoxazone主要通过肝脏细胞色素P450酶系统形成，在生化研究中常作为探针用于定量评估CYP2E1的活性。 | ||||
| GC42693 | Acetaminophen Glucuronide (sodium salt) | 120595-80-4 | >98.00% | |
An inactive metabolite of acetaminophen | ||||
| GC42694 | Acetaminophen sulfate (potassium salt) | 32113-41-0 | >98.00% | |
An inactive metabolite of acetaminophen | ||||
| GC42704 | Acetyl β-Endorphin (human) (trifluoroacetate salt) | - | >95.00% | |
An acetylated derivative of β-endorphin | ||||
| GC42809 | Angiotensin II (3-8) (human, rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide vasoconstrictor | ||||
| GC42865 | AT-121 | 2099681-31-7 | >95.00% | |
A dual μ-opioid and nociceptin receptor partial agonist | ||||
| GC42885 | AX 048 | 873079-69-7 | >98.00% | |
A cPLA 2 inhibitor | ||||
| GC42934 | Biocytin-β-Endorphin (human) (trifluoroacetate salt) | - | >95.00% | |
A biocytin-conjugated form of β-endorphin | ||||
| GC42990 | Bupivacaine | 38396-39-3 | >98.00% | |
A sodium channel blocker and local anesthetic | ||||
| GC43155 | CAY10448 | 1177195-52-6 | >98.00% | |
A potent capsaicin/TRPV1 antagonist | ||||
| GC43171 | CAY10568 | 22913-17-3 | >98.00% | |
A blocker of voltage-gated Na + ?channels | ||||
| GC43216 | CCR4 Antagonist (hydrochloride) | 1784252-84-1 | >98.00% | |
A CCR4 antagonist | ||||
| GC43327 | CTAP (trifluoroacetate salt) | - | >98.00% | |
An antagonist of the μ opioid receptor | ||||
| GC43373 | D-Amino Acid Oxidase Inhibitor | 39793-31-2 | >98.00% | |
An inhibitor of DAAO | ||||